Literature DB >> 21315768

Pre- and post-conditioning treatment with an ultra-low dose of Δ9-tetrahydrocannabinol (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage.

Fadi Assaf1, Miriam Fishbein, Mikhal Gafni, Ora Keren, Yosef Sarne.   

Abstract

Preconditioning, a phenomenon where a minor noxious stimulus protects from a subsequent more severe insult, and post-conditioning, where the protective intervention is applied following the insult, offer new insight into the neuronal mechanism(s) of neuroprotection and may provide new strategies for the prevention and treatment of brain damage. We have previously reported that a single administration of an extremely low dose of Δ(9)-tetrahydrocannabinol (THC; the psychoactive ingredient of marijuana) to mice induced minor long-lasting cognitive deficits. In the present study we examined the possibility that such a low dose of THC will protect the mice from more severe cognitive deficits induced by the epileptogenic drug pentylenetetrazole (PTZ). THC (0.002 mg/kg, a dose that is 3-4 orders of magnitude lower than the doses that induce the conventional effects of THC) was administered 1-7 days before, or 1-3 days after the injection of PTZ (60 mg/kg). The consequences of this treatment were studied 3-7 weeks later by various behavioral tests that evaluated different aspects of memory and learning. We found that a single administration of THC either before or after PTZ abolished the PTZ-induced long-lasting cognitive deficits. Biochemical studies indicated a concomitant reduction in phosphorylated-ERK (extracellular signal-regulated kinase) in the cerebella of mice 7 weeks following the injection of THC. Our results suggest that a pre- or post-conditioning treatment with extremely low doses of THC, several days before or after brain injury, may provide safe and effective long-term neuroprotection.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21315768     DOI: 10.1016/j.bbr.2011.02.005

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  12 in total

1.  A study on the mechanism by which MDMA protects against dopaminergic dysfunction after minimal traumatic brain injury (mTBI) in mice.

Authors:  S Edut; V Rubovitch; M Rehavi; S Schreiber; C G Pick
Journal:  J Mol Neurosci       Date:  2014-08-16       Impact factor: 3.444

Review 2.  Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies.

Authors:  Vamsi Reddy; Dayton Grogan; Meenakshi Ahluwalia; Évila Lopes Salles; Pankaj Ahluwalia; Hesam Khodadadi; Katelyn Alverson; Andy Nguyen; Srikrishnan P Raju; Pankaj Gaur; Molly Braun; Fernando L Vale; Vincenzo Costigliola; Krishnan Dhandapani; Babak Baban; Kumar Vaibhav
Journal:  EPMA J       Date:  2020-04-15       Impact factor: 6.543

3.  Long-term behavioral and biochemical effects of an ultra-low dose of Δ9-tetrahydrocannabinol (THC): neuroprotection and ERK signaling.

Authors:  Miriam Fishbein; Sahar Gov; Fadi Assaf; Mikhal Gafni; Ora Keren; Yosef Sarne
Journal:  Exp Brain Res       Date:  2012-07-22       Impact factor: 1.972

Review 4.  The dual neuroprotective-neurotoxic profile of cannabinoid drugs.

Authors:  Yosef Sarne; Fadi Asaf; Miriam Fishbein; Mikhal Gafni; Ora Keren
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

5.  Developmental exposure to Δ9-tetrahydrocannabinol (THC) causes biphasic effects on longevity, inflammation, and reproduction in aged zebrafish (Danio rerio).

Authors:  Zacharias Pandelides; Cammi Thornton; Kayla G Lovitt; Anika S Faruque; Alyssa P Whitehead; Kristine L Willett; Nicole M Ashpole
Journal:  Geroscience       Date:  2020-03-30       Impact factor: 7.713

Review 6.  A Molecular Approach to Epilepsy Management: from Current Therapeutic Methods to Preconditioning Efforts.

Authors:  Elham Amini; Mohsen Rezaei; Norlinah Mohamed Ibrahim; Mojtaba Golpich; Rasoul Ghasemi; Zahurin Mohamed; Azman Ali Raymond; Leila Dargahi; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2014-09-09       Impact factor: 5.590

Review 7.  Preconditioning as a potential strategy for the prevention of Parkinson's disease.

Authors:  Mojtaba Golpich; Behrouz Rahmani; Norlinah Mohamed Ibrahim; Leila Dargahi; Zahurin Mohamed; Azman Ali Raymond; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2014-04-03       Impact factor: 5.590

Review 8.  Role of MicroRNAs in innate neuroprotection mechanisms due to preconditioning of the brain.

Authors:  Eva M Jimenez-Mateos
Journal:  Front Neurosci       Date:  2015-04-21       Impact factor: 4.677

Review 9.  Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy.

Authors:  Mariana Babayeva; Haregewein Assefa; Paramita Basu; Sanjeda Chumki; Zvi Loewy
Journal:  Parkinsons Dis       Date:  2016-12-05

Review 10.  Endocannabinoids: A Promising Impact for Traumatic Brain Injury.

Authors:  Lesley D Schurman; Aron H Lichtman
Journal:  Front Pharmacol       Date:  2017-02-17       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.